• EN - English
  • NL - Nederlands
Parliamentary question - E-001092/2022Parliamentary question
E-001092/2022

Compromise agreement on the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver

Question for written answer  E-001092/2022/rev.1
to the Commission
Rule 138
Samira Rafaela (Renew)

Various media outlets reported on a breakthrough on a compromise regarding an intellectual property (IP) waiver to allow COVID‑19 vaccines to be produced in developing countries. The compromise between India, South Africa, the EU and the US is a very good and necessary development for expanding access to and the production of vaccines. However, the details of the compromise and its eventual adoption in the World Trade Organization (WTO) are key to moving forward with the IP waiver. Without broad support in the WTO, this compromise risks remaining an idea, instead of a solution.

Last updated: 11 August 2022
Legal notice - Privacy policy